Deleted Tweet from Scott Gottlieb, R-D.C.
Deleted Tweet from Scott Gottlieb, M.D.
SteveFDA (R-D.C.)
@SGottliebFDA
Politwoops no longer follows this account.
The new guidance also encourages sponsors to identify new biochemical or noninvasive imaging biomarkers that could eventually replace liver biopsies for monitoring progress and improvement, and that can be used for patient selection or for assessing efficacy in clinical trials.
It looks like this tweet was replaced by the next tweet from @SGottliebFDA.